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Immunization with myelin components can elicit experimental autoimmune encepha-
lomyelitis (EAE). EAE susceptibility varies between mouse strains, depending on the 
antigen employed. BL/6 mice are largely resistant to EAE induction with proteolipid pro-
tein (PLP), probably a reflection of antigen-specific tolerance. However, the extent and 
mechanism(s) of tolerance to PLP remain unclear. Here, we identified three PLP epitopes 
in PLP-deficient BL/6 mice. PLP-sufficient mice did not respond against two of these, 
whereas tolerance was “leaky” for an epitope with weak predicted MHCII binding, and 
only this epitope was encephalitogenic. In TCR transgenic mice, the “EAE-susceptibility-
associated” epitope was “ignored” by specific CD4 T cells, whereas the “resistance- 
associated” epitope induced clonal deletion and Treg induction in the thymus. Central 
tolerance was autoimmune regulator dependent and required expression and presen-
tation of PLP by thymic epithelial cells (TECs). TEC-specific ablation of PLP revealed 
that peripheral tolerance, mediated by dendritic cells through recessive tolerance
mechanisms (deletion and anergy), could largely compensate for a lack of central toler-
ance. However, adoptive EAE was exacerbated in mice lacking PLP in TECs, pointing 
toward a non-redundant role of the thymus in dominant tolerance to PLP. Our findings 
reveal multiple layers of tolerance to a central nervous system autoantigen that vary 
among epitopes and thereby specify disease susceptibility. Understanding how different 
modalities of tolerance apply to distinct T cell epitopes of a target in autoimmunity has 
implications for antigen-specific strategies to therapeutically interfere with unwanted 
immune reactions against self.
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inTrODUcTiOn
Experimental autoimmune encephalomyelitis (EAE) is an autoimmune demyelinating disease of 
the central nervous system (CNS) that develops in rodents after immunization with whole brain 
extract or purified myelin components (1, 2). It is characterized by infiltration of autoreactive CD4+ 
T cells and other inflammatory cells into the CNS. The pathophysiology and clinical symptoms 
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of EAE, including various degrees of paralysis, to some extent 
resemble the human disease multiple sclerosis (MS) (3).
Depending on the CNS autoantigen employed for immuniza-
tion, there is a considerable degree of variation between inbred 
mouse strains with regards to EAE susceptibility and disease 
course. For instance, B10.PL and PL/J mice are highly susceptible 
to disease induction with purified myelin basic protein (MBP) 
or particular MBP peptides, whereas many other mouse strains 
are resistant to MBP-induced EAE (4–6). The most commonly 
used encephalitogenic protocol for C57BL/6 (BL/6) mice relies 
on a particular myelin oligodendrocyte glycoprotein (MOG) 
peptide and results in a monophasic disease. Upon immuniza-
tion with myelin proteolipid protein (PLP), SJL/J mice develop a 
fulminant form of relapsing-remitting EAE, whereas most other 
strains, including BL/6, are considered largely “resistant” to PLP-
induced EAE (6–8).
Numerous genetic and non-genetic factors have been reported 
to modulate EAE susceptibility and disease severity in a complex 
fashion, but in many cases, the underlying molecular mecha-
nisms remain elusive (9, 10). Among the various inheritable 
traits that control the susceptibility to EAE in mice and MS in 
humans, the MHC is the by far most prominently associated 
genetic locus (9–11). Moreover, it is well established that the 
magnitude of the in vitro CD4 T cell response to myelin antigens 
in classical immunization recall experiments is a robust correlate 
of disease susceptibility. For instance, PLP-EAE susceptible SJL 
mice display a vigorous CD4 T cell response upon immunization 
with PLP protein or particular pools of PLP-peptides, whereas 
resistant strains such as BL/6, BALB/c, or CBA exhibit a much 
weaker response (7, 8). Although none of the strains that are 
susceptible to EAE induction with a given CNS protein develop 
spontaneous disease, it is undisputed that the composition and 
responsiveness of their CD4 T  cell compartment is a critical 
determinant of disease susceptibility.
CD4 T cells reactive to MBP or PLP are constituents of the 
normal human T cell repertoire (12–14). Limitations inherent to 
human studies so far preclude a conclusive assessment whether 
this in fact indicates the absence of antigen-specific tolerance or 
whether these autoreactive cells represent a residual fraction of 
the repertoire that has escaped tolerance induction. However, a 
precise understanding of how different modalities of tolerance 
shape the T cell reactivity to CNS autoantigens and how reces-
sive modes of tolerance, i.e., deletion and anergy, or dominant, 
i.e., Treg-mediated, tolerance cooperate and/or differentially 
apply to distinct T cell epitopes of a target in autoimmunity has 
implications for strategies that aim to therapeutically interfere 
with unwanted immune reactions against the CNS.
Mice lacking particular CNS autoantigens have been used to 
assess whether the magnitude and quality of the response to a 
given myelin protein is influenced by antigen-specific tole rance. 
MOG-specific CD4 T  cell responses were found to be identi-
cal between Mog+/+ and Mog–/– mice, and it was suggested that 
this apparent lack of tolerance to MOG explains the high patho-
genicity of the anti-MOG immune response in several mouse 
strains (15). By contrast, Mbp+/+ mice on the C3H or BALB/c 
background displayed a substantially weaker CD4 T cell response 
to MBP immunization than MBP-deficient mice, indicating that 
their T  cell repertoire is somehow curtailed by endogenously 
expressed MBP (16, 17). Using PLP knockout mice, we demon-
strated that the relatively moderate response of PLP-sufficient 
BL/6 mice to immunization with PLP is a consequence of 
specific tolerance rather than the reflection of an inherently low 
res ponsiveness (8).
The evidence for specific tolerance to the myelin antigens 
MBP and PLP is at odds with the originally held view that CNS 
proteins are topologically sequestered from the immune system. 
However, the idea that myelin antigens are exclusively expressed 
behind the blood–brain barrier, and thereby excluded from tol-
erance induction, has been largely abandoned (1). In case of PLP, 
mRNA transcripts are readily detectable in primary and second-
ary lymphoid organs (18, 19), and thymus chimeras revealed 
that the physiological expression of PLP in thymic epithelial 
cells (TECs) was sufficient to recapitulate the diminished CD4 
response of PLP-sufficient BL/6 mice (8).
CD4 T  cell tolerance to PLP in the “PLP-EAE-resistant” 
BL/6 strain has so far only been “operationally” defined as a 
reduced polyclonal CD4 T cell recall response upon immuniza-
tion compared to PLP-deficient mice. However, it was unclear 
through which cellular mechanism(s), that is, clonal deletion 
and/or diversion into the Foxp3+ Treg lineage, tolerance is 
achieved, and whether these modes of tolerance similarly 
apply to distinct epitopes of PLP. Furthermore, it remained 
open whether intrathymic PLP expression was “essential” for 
tolerance to PLP, both in terms of its impact on the fate of 
PLP-specific CD4 T cells as well as disease susceptibility. In the 
present study, we employed two novel strains of TCR transgenic 
mice in conjunction with strategies to selectively interfere with 
PLP expression or presentation in distinct cellular compart-
ments to obtain a comprehensive view of the modalities of CD4 
T cell tolerance to PLP.
resUlTs
PlP epitopes and epitope-specific  
eae susceptibility in Bl/6 Mice
We initially broadly defined the targets of CD4 T cell reactivity 
to PLP in “non-tolerant” PlpKO BL/6 mice through re-stimulating 
lymph node T cells from immunized mice with a set of overlap-
ping 25-mer peptides corresponding to the entire PLP protein 
(Figure 1A) (8). The PLPko mouse used in our study has been 
characterized extensively with regards to a verification of the 
absence of PLP protein or any truncated version thereof (20). 
Overlapping 12-mer peptides spanning these regions were 
then used to precisely fine-map the respective I-Ab-restricted 
epitopes (Figure  1B). This revealed three core 9-mer epitopes 
spanning amino acids 11–19, 174–182, and 240–248, in the 
following referred to as epitopes #1, #2, and #3, respectively. 
The experimental epitope definition was retrospectively com-
bined with an in  silico prediction of T  cell epitopes using the 
Immune Epitope Database and Analysis Resource (IEDB) (21, 22). 
The IEDB algorithm predicts and ranks the relative binding 
strengths of all 15-mer peptides that can be generated from a 
given protein. For PLP, the seven 15-mer peptides containing 
FigUre 1 | Proteolipid protein (PLP) epitopes and epitope-specific experimental autoimmune encephalomyelitis (EAE) susceptibility in BL/6 mice. (a) PlpKO BL/6 
mice were immunized with PLP protein. Nine days later, draining lymph node cells were re-stimulated in vitro with overlapping 25-mers spanning the entire PLP 
protein. Responses to peptides are shown as proliferation indices. (B) Fine mapping of epitopes with overlapping 12-mer peptides. (c) CD4 T cell recall response  
of PlpKO or PlpWT mice upon immunization with 12-mer peptides containing the core epitopes #1, #2, and #3. (D) EAE symptoms in PlpWT mice upon immunization 
with the 12-mer peptides PLP9–20 (n = 6) or PLP172–183 (n = 7) together with administration of pertussis toxin on days 0 and 2. Data in panels (a–c) are from individual 
mice representative for n ≥ 5 each.
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epitope #3 were among the top eight predicted I-Ab binders, and 
all of the 15-mers harboring epitope #1 were ranked between 
positions 10 and 20 (Figure S1 in Supplementary Material). 
Epitope #2-containing 15-mers had the weakest binding scores 
and ranked between positions 33 and 57. Consistent with this 
relative ranking, an in silico prediction of MHC-binding affinities 
using the SSM-align algorithm (23) yielded mean IC50 values of 
168 ± 61 nM for epitope #3-containing peptides and 715 ± 262 
or 1,533 ±  498  nM for peptides containing epitopes #1 or #2, 
respectively.
Compared to the pronounced CD4 T  cell responses to all 
three epitopes in PlpKO mice, there was essentially no recall res-
ponse to epitopes #1 and #3 with cells from immunized PlpWT 
mice (Figure  1C). However, a robust response to epitope #2 
was observed, although the magnitude of this response was 
somewhat attenuated as compared to PlpKO mice. To assess how 
the absence or presence of CD4 T cell responsiveness to these 
PLP epitopes correlated with EAE susceptibility, we immunized 
PlpWT mice with epitopes #1, #2, or #3 according to the EAE 
protocol. Whereas “EAE-immunization” with epitope #1 and 
epitope #3 failed to promote disease symptoms, epitope #2 
elicited EAE with a typical acute disease course, that is, onset 
of symptoms at around day 8, followed by a disease peak at 
days 14–16 and subsequent remission (Figure  1D, and data 
not shown).
Together, these observations reveal a differential impact of 
self-tolerance on CD4 T cell responses to three distinct epitopes 
of PLP in BL/6 mice. Tolerance was “leaky” for the epitope with 
the lowest predicted MHC II-binding capacity. Moreover, the 
absence or presence of recall responsiveness to a given epitope 
tightly correlated with resistance or susceptibility to EAE, 
respectively.
“ignorance” toward PlP epitope #2
In order to follow the fate of epitope #2-specific CD4 T cells and 
characterize the apparent “failure” of tolerance induction to this 
epitope, we generated transgenic mice (TCR-PLP2) expressing 
a PLP172–183-specific TCR that was derived from immunized 
PlpKO mice. In TCR-PLP2 PlpKO mice, i.e., in the absence of 
cognate self-antigen, there was a pronounced skewing toward 
the CD4 lineage in the thymus, and the vast majority of CD4 
single-positive (SP) thymocytes expressed the transgenic TCR 
chains (Vα2 and Vβ14) (Figure  2A). A very small fraction of 
Vα2+Vβ14+ CD4 SP cells expressed Foxp3. Importantly, none 
of these parameters was altered in TCR-PLP2 PlpWT mice, 
indicating that PLP epitope #2-specific CD4 T  cells were not 
subject to central tolerance induction (Figure  2A). Also in 
the periphery, neither the frequency of CD4 T  cells nor their 
expression of Vα2+Vβ14+ was different between TCR-PLP2 
mice on Plp-deficient or -sufficient background, suggesting that 
epitope #2-specific T  cells in both settings persisted as naïve 
cells (Figure  2B). Consistent with this, purified CD4 T  cells 
from TCR-PLP2 PlpWT displayed an identical in vitro prolifera-
tive response to stimulation with titrated amounts of PLP172–183 
as cells from TCR-PLP2 PlpKO controls (Figure 2C). Adoptively 
transferred naïve TCR-PLP2 cells from PlpKO mice persisted in a 
non-dividing state in PlpWT recipients, whereas cells from both 
TCR-PLP2 PlpKO or TCR-PLP2 PlpWT origin proliferated upon 
challenge with cognate peptide, irrespective of being parked in a 
Plp-deficient or -sufficient recipient (Figure 2D). These findings 
further substantiated the idea that PLP epitope #2 of natural 
origin is not sufficiently processed and presented from physi-
ological sources to become “visible” to peripheral CD4 T cells. 
However, “EAE-immunization” with peptide PLP172–183 elicited 
EAE in TCR-PLP2 PlpWT mice, suggesting that these TCR trans-
genic cells can turn into pathogenic effectors upon appropriate 
stimulation and recognize the physiologically processed epitope 
(Figure 2E).
Thus, PLP172–183-specific TCR transgenic CD4 T  cells with 
encephalitogenic potential were not subject to tolerance induc-
tion. Instead, they persisted in a state of “ignorance” that was 
broken upon immunogenic delivery of cognate antigen, in line 
with the capacity of PLP172–183 immunization to elicit EAE in a 
polyclonal setting.
spontaneous eae in Tcr-PlP2  
rag1–/– Mice
The expression of an endogenously rearranged TCRα chain 
together with the transgenic TCR elements may result in a dual 
specificity and thereby complicate the interpretation of TCR 
instructed cell fate decisions. For instance, the emergence of a 
small population of Foxp3+ cells among Vα2+Vβ14+ cells in both 
thymus and periphery of TCR-PLP2 mice was PLP independent, 
and thus likely to reflect a “cryptic autoreactivity” conveyed by 
endogenous TCR rearrangements. To assess the consequences 
of excluding endogenous TCR rearrangements, we generated 
Rag1-deficient TCR-PLP2 mice. Irrespective of an intact Plp 
gene, this resulted in the virtual absence of Foxp3+ cells from 
thymus and periphery. Importantly, as in Rag1+/+ mice, the 
frequency and absolute number TCR-PLP2+ cells was indistin-
guishable between Plp-deficient or –sufficient mice, confirming 
that their cognate antigen PLP172–183 is essentially “invisible” to 
these cells (Figures  3A,B). However, in contrast to mice on 
Rag1+/+ background, PLP-sufficient TCR-PLP2 Rag1–/– mice 
developed “spontaneous” EAE starting at around 5 weeks of age 
(Figures 3C,D).
These observations confirmed that TCR-PLP2+ CD4 T cells 
can be pathogenic, yet do not encounter cognate antigen during 
thymic differentiation or in the periphery, so that they initially 
remain in a state of “ignorance.” However, in a truly monoclonal 
setting their latent autoimmune potential can with increasing 
age be “spontaneously” unleashed, possibly facilitated by the 
lack of Treg cells.
central Tolerance toward PlP epitope #1
In contrast to our observations with the “EAE-susceptibility-
associated” epitope #2, BL/6 mice did not display a CD4 T cell 
recall response to epitope #1 and were resistant to EAE induction 
by immunization with this peptide (see Figure 1). In order to 
characterize the mode of CD4 T cell tolerance induction to the 
“EAE-resistance-associated” epitope #1, we generated a PLP11–19-
specific TCR transgenic mouse strain (TCR-PLP1). Compared 
to TCR-PLP1 PlpKO controls, the frequency and number of CD4 
FigUre 2 | “Ignorance” toward proteolipid protein (PLP) epitope #2 in TCR-PLP2 transgenic mice. (a) Thymocyte subset composition of TCR-PLP2 transgenic 
mice on PlpKO or PlpWT background. The average frequency ± SEM of CD4SP cells (upper plot), TCR-PLP2+ cells (Vα2+Vβ14+) among gated CD4SP thymocytes 
(middle), and CD25+Foxp3+ cells among gated TCR-PLP2+ CD4SP cells is indicated (n ≥ 8 per genotype). The bar diagrams on the right show absolute cell 
numbers of the respective subsets. (B) Peripheral phenotype of TCR-PLP2 transgenic mice on PlpKO or PlpWT background. The average frequency ± SEM of CD4 
T cells (upper plot), TCR-PLP2+ cells (Vα2+Vβ14+) among gated CD4 T cells (middle) and CD25+Foxp3+ cells among gated TCR-PLP2+ CD4 T cells (lower) are 
indicated (n ≥ 8 per genotype). (c) Proliferation of purified CD4 T cells from TCR-PLP2 transgenic mice on PlpKO or PlpWT background upon in vitro stimulation with 
PLP172–183. Data are from individual mice representative for n ≥ 3 each. (D) CFSE-labeled CD4 T cells from PlpKO or PlpWT TCR-PLP2 transgenic mice (CD45.2) were 
i.v. injected into PlpWT recipients (CD45.1) that had (right) or had not (left) been immunized with PLP172–183 the day before. Four days later, lymph node cells were 
harvested and analyzed by FACS. Histograms show the CFSE intensity of gated CD4+CD45.2+ cells. The filled histogram overlay is from undivided control cells in a 
PlpKO recipient. Data are representative of three experiments with n = 5 each. (e) Experimental autoimmune encephalomyelitis (EAE) disease course in TCR-PLP2 
PlpWT mice upon immunization with the 12-mer peptide PLP172–183 together with administration of pertussis toxin on days 0 and 2 (n = 14).
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SP cells in the thymus of TCR-PLP1 PlpWT mice were strongly 
diminished (Figure  4A). Moreover, whereas in PLP-deficient 
mice, around 85% of CD4 SP cells expressed both transgenic 
TCR chains, only about 50% of CD4 SP cells were Vα3.2+Vβ6+ 
in PLP-sufficient mice. Among the remaining TCR-PLP1+ CD4 
SP cells in PLPWT mice, an elevated frequency of cells was Foxp3+, 
whereby in terms of absolute numbers, this reflected an only 
moderate, yet significant, increase (Figure  4A). In peripheral 
lymphoid organs of TCR-PLP1 PlpWT mice, the proportion of 
CD4+ T  cells was reduced by about fourfold when compared 
to PlpKO controls (Figure 4B). Whereas in PLP-deficient mice, 
around 75% of peripheral CD4 T  cells expressed the trans-
genic TCR, less than 10% of peripheral CD4+ T cells did so in 
TCR-PLP1 PlpWT mice. TCR-PLP1+ CD4 T cells contained only 
a minute fraction of Foxp3+ cells in PLP-deficient mice, while 
Foxp3+ cells constituted more than a third of TCR-PLP1+ cells in 
PlpWT mice (Figure 4B).
To ask whether the segregation of peripheral TCR-PLP1+ cells 
in PLP-sufficient mice into Foxp3+ and Foxp3– cells reflected the 
co-existence of Treg cells and bona fide naïve cells, we assessed the 
functional properties of both subsets. Purified CD25+ cells indeed 
suppressed the proliferation of naïve TCR-PLP1 Tconv cells in an 
antigen-specific manner (Figure  4C). However, whereas naïve 
TCR-PLP1 cells from PLP-deficient donors vigorously prolifer-
ated upon adoptive transfer into PlpWT recipients, illustrating that 
I-Ab/PLP11–19 ligands of physiological origin are constitutively 
FigUre 3 | Spontaneous experimental autoimmune encephalomyelitis (EAE) in TCR-PLP2 transgenic mice on Rag1-deficient background. (a) Thymocyte subset 
composition of TCR-PLP2 transgenic Rag1–/– mice on PlpKO or PlpWT background. The average frequency ± SEM of CD4SP cells (upper plot), TCR-PLP2+ cells 
(Vα2+Vβ14+) among gated CD4SP thymocytes (middle) and CD25+Foxp3+ cells among gated TCR-PLP2+ CD4SP cells (lower) is indicated (n ≥ 9 each). The bar 
diagrams on the right show absolute cell numbers of the respective subsets. (B) Peripheral phenotype of TCR-PLP2 transgenic mice on PlpKO or PlpWT background. 
The average frequency ± SEM of CD4 T cells (upper plot), TCR-PLP2+ cells (Vα2+Vβ14+) among gated CD4 T cells (middle) and CD25+Foxp3+ cells among gated 
TCR-PLP2+ CD4 T cells (lower) are indicated (n ≥ 9 each per genotype). (c,D) Cumulative incidence and maximum disease score of spontaneous EAE in 
TCR-PLP2 Rag1–/– (n = 21) and TCR-PLP2 Rag1+/+ mice (n = 6).
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“visible” in peripheral lymphoid tissues, co-transferred CD25– 
TCR-PLP1+ cells from TCR-PLP1 PlpWT mice did not proliferate, 
indicating that these cells were in a cell intrinsic refractory state 
of anergy (Figure 4D).
We did not observe spontaneous EAE in TCR-PLP1 PlpWT 
mice. In order to assess the “autoimmune potential” of TCR-
PLP1 CD4 T cells, we generated TCR-PLP1 Rag1–/– PlpKO mice. 
Monoclonal TCR-PLP1 CD4 T cells from these donors were dif-
ferentiated in vitro into Th1 or Th17 effectors and subsequently 
transferred into Rag1–/– PlpWT recipients, revealing that both 
Th1- or Th17-polarized cells induced EAE, albeit with a slightly 
lower maximal disease score in the case of Th1 cells (Figure 4E).
In sum, these data showed that PLP epitope #1-specific 
CD4 T  cells bear autoimmune potential, which was at least in 
part harnessed through tolerance induction during intrathymic 
T cell differentiation. The predominant mode of central tolerance 
induction among TCR-PLP1 CD4 T cells appeared to be clonal 
deletion. At the same time, a fraction of cells differentiated into 
Treg cells and efficiently seeded peripheral lymphoid organs, were 
they co-existed with anergic Foxp3–CD25– TCR-PLP1 cells.
FigUre 4 | Central tolerance to proteolipid protein (PLP) epitope #1 in TCR-PLP1 transgenic mice. (a) Thymocyte subset composition of TCR-PLP1 transgenic mice 
on PlpKO or PlpWT background. The average frequency ± SEM of CD4SP cells (upper plot), TCR-PLP1+ cells (Vα3.2+Vβ6+) among gated CD4SP thymocytes (middle) 
and CD25+Foxp3+ cells among gated TCR-PLP1+ CD4SP cells is indicated (n ≥ 8 mice per genotype). The bar diagrams on the right show absolute cell numbers of the 
respective subsets. (B) Peripheral phenotype of TCR-PLP1 transgenic mice on PlpKO or PlpWT background. The average frequency ± SEM of CD4 T cells (upper plot), 
TCR-PLP1+ cells (Vα3.2+Vβ6+) among gated CD4 T cells (middle) and CD25+Foxp3+ cells among gated TCR-PLP1+ CD4 T cells (lower) are indicated (n ≥ 8 mice per 
genotype). (c) Purified naïve TCR-PLP1+ CD4 T cells from TCR-PLP1 PlpKO mice were labeled with CFSE and cultured in vitro with irradiated splenoctyes and peptide 
PLP9–20 in the presence or absence of titrated numbers of TCR-PLP1+CD25+ CD4 T cells from TCR-PLP1 PlpWT mice. The histogram overlay shows a representative 
CFSE profile on day 3 of cells when cultured alone (gray histogram) or with an equal number of Treg cells (open histogram). The diagram on the right shows the dose/
response curve with different ratios of Treg cells. (D) Purified TCR-PLP1+CD25– CD4 T cells from TCR-PLP1 mice on PlpWT (CD45.2) or PlpKO background (CD45.1/2) 
were labeled with CFSE and co-injected i.v. into PlpWT (CD45.1) recipients. Three days after transfer, lymph node cells were harvested and stained for CD45.1 and 
CD45.2. The dot plot on the left shows the relative abundance of cells of PlpWT (CD45.2; red gate) or PlpKO origin (CD45.1/2; blue gate). The histogram overlay on the 
right shows the CFSE profile of the respective cells. Data are representative of two independent experiments with n ≥ 3 each. (e) Disease course of “adoptive” 
experimental autoimmune encephalomyelitis (EAE) in Rag1–/– recipients after transfer of Th1- or Th17-polarized TCR-PLP1+ CD4 T cells from TCR-PLP1 PlpKO mice.
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FigUre 5 | Thymic epithelial cell (TEC)-derived proteolipid protein (PLP) and autoimmune regulator (Aire) are crucial for central tolerance to epitope #1. (a) Relative 
abundance of PLP mRNA in different subsets of TECs, thymic dendritic cells (DCs), and CD4 single-positive (SP) cells. Values are indicated as arbitrary units (AU) 
normalized to expression in DCs. Data are representative of two independent experiments with pooled cells from ≥3 mice. (B) CD4 versus CD8 staining of thymus 
cells from TCR-PLP1 transgenic mice on PlpKO, PlpWT, or PlpΔTEC background. (c) Average frequency ± SEM of CD4SP cells (left), TCR-PLP1+ cells (Vα3.2+Vβ6+) 
among gated CD4SP thymocytes (middle) and CD25+Foxp3+ cells among gated TCR-PLP1+ CD4SP cells (right) in TCR-PLP1 mice on PlpKO, PlpWT, or PlpΔTEC 
background (n = 4 each). (D) Average frequency ± SEM of CD4SP cells (left), TCR-PLP1+ cells (Vα3.2+Vβ6+) among gated CD4SP thymocytes (middle), and 
CD25+Foxp3+ cells among gated TCR-PLP1+ CD4SP cells (right) in TCR-PLP1 mice on PlpKO (n = 3), PlpWT (n = 3), or PlpWT Aire–/– (n = 6) background.
8
Wang et al. Differential Tolerance to PLP Epitopes
Frontiers in Immunology | www.frontiersin.org November 2017 | Volume 8 | Article 1511
Tec-Derived PlP and autoimmune 
regulator (aire) are crucial for central 
Tolerance to epitope #1
We previously reported that PlpWT →  PlpKO thymus chimeras, 
where TECs are the sole potential source of tolerizing antigen, 
recapitulated the “operational tolerance” of PlpWT mice, as evi-
dent from a similar reduction of the CD4 T cell recall response 
after immunization compared to PlpKO mice (8). This indicated 
that PLP expression in TECs was sufficient for CD4 T cell toler-
ance. Given that PLP transcripts are also detectable in dendritic 
cells (DCs), albeit at substantially lower levels (Figure 5A), we 
wondered whether TEC-derived PLP was in fact essential for 
central tolerance, or whether there was a degree of redundancy 
with other potential intra- or extrathymic sources of tolerizing 
antigen. To address this, we generated mice with a conditional 
deletion of the Plp gene in TECs (Foxn1-Cre Plpfloxed), in the 
following referred to as PlpΔTEC. Strikingly, all manifestations 
of central tolerance in the TCR-PLP1 system were abolished in 
PlpΔTEC mice (Figures 5B,C). Thus, both the frequency of CD4 
SP cells as well as the proportion of Vα3.2+Vβ6+ among CD4 SP 
cells were indistinguishable from those observed in the complete 
absence of PLP in PlpKO mice. In the same vein, the frequency of 
Foxp3+ cells among TCR-PLP1 CD4 SP cells of PlpΔTEC mice was 
identical to that in “antigen-free” PlpKO mice.
The “promiscuous” transcription of peripheral antigens in 
the thymus is mostly confined to “mature” medullary thymic 
epithelial cells (mTECs) expressing high levels of MHCII, and this 
reflects the predominant expression of the transcriptional activa-
tor Aire in this cell type. PLP’s intrathymic expression pattern is 
rather untypical for a promiscuously expressed tissue-restricted 
antigen in that it is also detectable in “immature” (MHCIIlo) 
mTECs and at comparable levels also in cortical thymic epithelial 
cells (cTECs) (Figure  5A). Since MHCIIlo mTECs and cTECs 
FigUre 6 | Central proteolipid protein (PLP) tolerance is dendritic cell (DC) independent and requires direct presentation by medullary thymic epithelial cells.  
(a) CD4 versus CD8 staining of thymus cells from TCR-PLP1 transgenic mice on PlpKO, PlpWT, or PlpWT ΔDC background. (B) Average frequency ± SEM of  
CD4SP cells (left), TCR-PLP1+ cells (Vα3.2+Vβ6+) among gated CD4SP thymocytes (middle) and CD25+Foxp3+ cells among gated TCR-PLP1+ CD4SP  
cells (right) in TCR-PLP1 mice on PlpKO (n = 3), PlpWT (n = 7), or PlpWT ΔDC (n = 7) background. (c) Average frequency ± SEM of CD4SP cells (left),  
TCR-PLP1+ cells (Vα3.2+Vβ6+) among gated CD4SP thymocytes (middle) and CD25+Foxp3+ cells among gated TCR-PLP1+ CD4SP cells (right) in  
TCR-PLP1 mice on PlpKO (n = 6), PlpWT (n = 8), or PlpWT C2TAkd (n = 5) background.
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barely, or not at all, express Aire, respectively, we hypothesized 
that central tolerance to PLP was Aire independent. However, 
both negative selection and Treg induction were abrogated in 
Aire-deficient TCR-PLP1 PlpWT mice, so that the thymocyte 
composition in these mice phenocopied that in TCR-PLP1 PlpKO 
and TCR-PLP1 PlpΔTEC mice (Figure 5D).
Together, these data showed that PLP expression in TECs 
was necessary and sufficient for central tolerance induction in 
PLP epitope #1-specific CD4 T cells. Intriguingly, although PLP 
transcripts were not confined to Aire-expressing mTEChi cells, 
intrathymic tolerance induction to PLP depended upon Aire.
central PlP-Tolerance is Dc independent 
and requires Presentation by mTecs
Self-antigens that are expressed in TECs may be presented to 
developing CD4 T cells via two distinct, yet mutually not exclusive 
routes (24). On the one hand, tolerogenic encounter of such anti-
gens by CD4 T cells may depend upon “antigen handover” and 
presentation by thymic DCs. On the other hand, mTECs, or TECs 
in general, may autonomously present endogenously expressed 
antigen to CD4 T cells via unconventional MHC class II-loading 
pathways (25).
Two experimental systems were employed to address this 
issue in the TCR-PLP1 model. First, we generated TCR-PLP1 
PlpWT mice lacking DCs as a result of diphtheria toxin expression 
in CD11c+ cells (“ΔDC” mice) (26). Despite the lack of DCs, 
the thymic phenotype of these mice was essentially identical 
to that of DC-sufficient TCR-PLP1 PlpWT mice (Figures 6A,B). 
Second, we generated TCR-PLP1 mice with an impaired capac-
ity to directly present antigen on mTECs as a consequence 
of mTEC-specific knock-down of MHC class II (“C2TAkd” 
mice) (27). All manifestations of central tolerance induction 
to PLP epitope #1 were significantly attenuated in these mice. 
FigUre 7 | Phenotype and functionality of TCR-PLP1 cells in PlpΔTEC and Δdendritic cell (DC) mice. (a) Peripheral phenotype of TCR-PLP1 transgenic mice  
on PlpKO (n = 8), PlpWT (n = 9), PlpΔTEC (n = 3), or PlpWT ΔDC (n = 7) background. The average frequency ± SEM of CD4 T cells (upper plot), TCR-PLP1+ cells 
(Vα3.2+Vβ6+) among gated CD4 T cells (middle) and CD25+Foxp3+ cells among gated TCR-PLP1+ CD4 T cells (lower) are indicated. (B) Purified TCR-PLP1+CD25– 
CD4 T cells from TCR-PLP1 mice on PlpKO, PlpWT, PlpΔTEC, or PlpWT ΔDC background (all CD45.2) were labeled with CFSE and injected i.v. into PlpWT (CD45.1) 
recipients. Three days after transfer, lymph node cells were harvested and CFSE dilution was assessed on gated CD45.2+ cells. Data are representative  
of n ≥ 4. (c) Purified TCR-PLP1+CD25–CD4 T cells from TCR-PLP1 mice on PlpKO background (CD45.1) were labeled with CFSE and injected i.v. into PlpWT or PlpWT 
ΔDC recipients (CD45.2). Three days after transfer, lymph node cells were harvested and CFSE dilution was assessed on gated CD45.2+ cells. The gray histogram 
shows the CFSE-intensity of cells transferred into control PlpKO recipients. Data are representative of n ≥ 6. (D) Purified TCR-PLP1+ CD4 T cells from TCR-PLP1 
mice on PlpKO background (CD45.1) were labeled with CFSE and i.v. injected into bone marrow (BM)-chimeric recipients (MHCII+/+ → PlpWT controls, 
MHCII–/– → PlpWT, and MHCII+/+ → PlpKO) (CD45.2). Three days after transfer, lymph node cells were harvested and CFSE dilution was assessed on  
gated CD45.2+ cells. (e) Experimental autoimmune encephalomyelitis (EAE) disease course in male PlpWT or PlpΔTEC mice (non-TCR-transgenic) that  
had been injected i.v. with 5 × 106 TCR-PLP1+ T cells from TCR-PLP1 PlpKO mice 6 h before administration of PLP9–20 in CFA. Data are from n ≥ 14 each.
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Specifically, the proportion of CD4 SP cells, the percentage of 
Vα3.2+Vβ6+ among CD4 SP cells and the relative abundance of 
TCR-PLP1+ Foxp3+ CD4 SP cells were all partially “rescued,” i.e., 
they ranged in between TCR-PLP1 PlpWT and TCR-PLP1 PlpKO 
mice (Figure 6C).
Collectively, these findings documented a non-redundant 
role of mTECs for central tolerance induction to PLP epitope #1 
through direct presentation of endogenously derived antigen. 
Intrathymic presentation by DCs, if occurring at all, was dispen-
sable for central tolerance.
Peripheral Tolerance in PlpΔTec Mice
Although the conditional deletion of PLP in TECs abolished 
central tolerance to PLP epitope #1, neither PlpΔTEC mice nor 
TCR-PLP1 transgenic PlpΔTEC mice developed spontaneous EAE 
(data not shown). Even the active immunization of these mice 
with the epitope #1-containing peptide PLP11–20 according to the 
“EAE protocol” failed to promote disease symptoms (data not 
shown), suggesting that peripheral tolerance mechanisms were 
able to compensate for the absence of intrathymic censorship.
Indeed, the CD4 T cell compartment in secondary lymphoid 
tissues of TCR-PLP1 PlpΔTEC mice exhibited clear indications of 
peripheral antigen encounter. Thus, despite an identical thymo-
cyte composition as in TCR-PLP1 PlpKO mice (see Figures 5B,C), 
there was a marked reduction in the overall size of the peripheral 
CD4 T cell population in TCR-PLP1 PlpΔTEC mice (Figure 7A). 
Although this resembled a similar CD4 T  cell reduction in 
TCR-PLP1 PlpWT mice, PlpΔTEC mice had a substantially higher 
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percentage of TCR-PLP1+ cells among peripheral CD4 T  cells 
(47.9 ±  5.1 versus 8.9 ±  0.8%; P <  0.001). The proportion of 
Foxp3+ Treg cells among TCR-PLP1+ CD4 T cells in PlpΔTEC mice 
was as low as in fully PLP-deficient mice, suggesting that PLP 
expression in TECs was crucial for the establishment of the 
prominent peripheral TCR-PLP1+Foxp3+ Treg population in 
TCR-PLP1 PlpWT mice. By contrast, the CD25– subset of TCR- 
PLP1+ cells from PlpΔTEC mice functionally resembled the cor-
responding population in PlpWT mice with respect to being 
refractory to antigenic stimulation in vivo (Figure 7B), indicat-
ing that anergy induction occurred independent of thymic PLP 
encounter. Consistent with this, the anergy marker FR4 was 
similarly elevated on Foxp3–CD25–TCR-PLP1+ cells from both 
PlpΔTEC and PlpWT mice (Figure S2 in Supplementary Material). 
These data showed that in the absence of PLP expression in TECs, 
peripheral tolerance toward PLP epitope #1 appeared to operate 
via deletional mechanisms and anergy induction rather than 
Treg conversion.
Peripheral Tolerance induction through 
Presentation of “non-hematopoietic”  
PlP by Dcs
Ablation of thymic PLP expression in PlpΔTEC mice revealed 
that “downstream” of the thymus, peripheral antigen encounter 
could shape the fate of TCR-PLP1 CD4 T cells. To ask whether 
presentation of I-Ab/PLP11–19 ligands in the periphery was DC 
dependent, we transferred CFSE-labeled TCR-PLP1 cells into 
DC-sufficient or DC-deficient PlpWT mice. Whereas transferred 
cells vigorously proliferated in control recipients, they failed to 
do so in ΔDC mice, indicating that antigen presentation by DCs 
was crucially involved (Figure 7C).
To address whether the display of PLP epitope #1 by periph-
eral DCs reflected the presentation of endogenously derived 
PLP or required the uptake and presentation of PLP from a non-
hematopoietic source, we performed analogous experiments with 
bone marrow (BM) chimeric recipients (Figure  7D). Whereas 
TCR-PLP1 cells underwent proliferation when transferred into 
MHCII+/+ →  PlpWT control chimeras, they remained quiescent 
in MHCII–/– →  PlpWT chimeras, consistent with a requirement 
for antigen presentation by DCs. Importantly, transferred cells 
likewise failed to proliferate in MHCII+/+  →  PlpKO chimeras, 
establishing that PLP from a non-hematopoietic source was cru-
cially required.
Considering that in PlpWT mice, PLP was concomitantly 
presented intrathymically by mTECs as well as in the periphery 
by DCs, we wondered in how far the peripheral composition and 
functionality of TCR-PLP1+ cells was shaped by thymic output 
versus peripheral tolerance induction. The striking phenotypic 
similarity between DC-sufficient and DC-deficient TCR-PLP1 
PlpWT mice (compare Figures 6A,B) also applied to the periph-
ery (Figure  7A). Specifically, total CD4 cells were reduced 
to the same extent, and the comparably small populations of 
TCR-PLP1+ cells in both genotypes similarly segregated into 
Foxp3+ Tregs and Foxp3–CD25– cells, suggesting that the overall 
composition of the TCR-PLP1+ CD4 T  cell pool was mostly 
shaped by thymic output. Interestingly, though, CD25– cells from 
ΔDC mice proliferated upon adoptive transfer into PlpWT mice 
(Figure  7B), indicating that the anergic state of these cells in 
DC-sufficient mice is induced and/or maintained by peripheral 
antigen encounter on DCs.
Our findings suggested that the lack of thymic negative 
selection in TCR-PLP1 PlpΔTEC mice could be largely compensa-
ted by DC-mediated peripheral deletion and anergy induction, 
while the “normal” formation of a PLP-specific peripheral Treg 
com partment appeared to depend on thymic Treg induction by 
mTECs. Given this differential degree of redundancy bet ween 
thymic and peripheral antigen encounter with respect to reces-
sive versus dominant tolerance mechanisms (deletion and 
anergy versus Treg induction, respectively), we sought evidence 
for a defect in dominant tolerance to PLP in the polyclonal 
repertoire of non-TCR transgenic PlpΔTEC mice. To do so, we 
adoptively transferred naïve TCR-PLP1 cells into PlpΔTEC or PlpWT 
mice simultaneously to “EAE-immunization” with PLP11–20. This 
resulted in the development of EAE in both genotypes. However, 
the disease course was more severe in mice lacking thymic 
PLP expression, consistent with a “less robust” state of tolerance, 
possibly owing to lack or diminution of PLP-specific Treg cells 
(Figure 7E).
DiscUssiOn
The present study establishes a number of salient features of 
tolerance to PLP in BL/6 mice. The fine mapping of the protein 
domains against which the uncensored CD4 T cell repertoire of 
PLP-deficient mice reacts identified three core I-Ab-restricted 
epitopes. PLP-sufficient mice failed to mount a response against 
epitopes #1 and #3, yet reacted toward epitope #2. This corre-
lated tightly with the encephalitogenic potential of the respective 
peptides when administered according to the standard EAE 
protocol, indicating that the extent of CD4 T  cell tolerance 
varied between epitopes. Interestingly, epitope #2 overlaps with 
a peptide that is commonly used to elicit EAE in SJL/J (H-2s) 
mice, but was shown to bear encephalitogenic potential also in 
BL/6 mice (28, 29).
The precise determinants underlying the differential degree 
of tolerance of BL/6 mice to the I-Ab restricted epitopes #1 
(PLP11–19) and #3 (PLP240–248) on the one hand and epitope #2 
(PLP174–182) on the other hand remain to be established. In SJL 
mice, a similar lack of tolerance to the I-As-restricted encepha-
litogenic peptide PLP139–151, at least as far as central tolerance 
induction is concerned, is readily explained by the fact that 
expression of PLP in TECs is confined to the DM20 splice 
variant that lacks the amino acid residues 116–151 (8, 30). 
However, such a splicing-related “hole in the proteome” can-
not account for the leakiness of central tolerance to epitope 
#2, since all three I-Ab-restricted PLP epitopes are contained 
within the intrathymically expressed DM20 protein isoform 
and should therefore be available for processing and presenta-
tion in stoichiometric amounts. Hence, the most likely expla-
nation for the lack of central tolerance to epitope #2 might be 
that this peptide is a weaker I-Ab binder than epitopes #1 and 
#3. A scenario whereby escape from central tolerance due to 
weak or unfavorable MHCII binding explains the autoimmune 
association of a given self-epitope is reminiscent of what has 
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been suggested regarding the major insulin-epitope recognized 
by diabetogenic CD4 T cells in NOD mice (H-2q7) (31, 32) and 
the encephalitogenic MBP epitope MBP1–11 in H-2u mice (33). 
An expe rimental verification of the predicted I-Ab-binding 
hierarchy of PLP epitopes will be necessary to further substan-
tiate this notion.
Weak I-Ab binding would also offer an explanation why 
epitope #2 appears to be insufficiently presented in the periph-
ery and therefore “ignored” by specific CD4 T cells, whereas 
epitope #1 is constitutively available for T  cell recognition 
and, under steady state conditions, peripheral tolerance induc-
tion. Despite the caveat that our study is limited to the fate of 
individual transgenic TCRs, we deem it likely that escape from 
thymic censorship and “ignorance” in the periphery is repre-
sentative of the fate of a sizeable fraction of epitope #2-specific 
CD4 T cells in the polyclonal repertoire. Thus, despite intra-
thymic expression of PLP, EAE can be elicited in BL/6 mice by 
immunogenic delivery of this determinant, indicating that a 
sufficiently large pool of “naïve” epitope #2 reactive CD4 T cells 
exists.
Breeding onto a Rag-deficient background, although only 
modestly increasing the frequency of clonotype-positive cells, 
rendered TCR-PLP2 mice susceptible to spontaneous EAE 
development. This is reminiscent of a similar phenomenon in 
H-2u mice carrying an MBP1–11-specific TCR (34). In the latter 
model, it was shown that Treg cells, whose differentiation requires 
endogenous TCRα rearrangements conferring specificity to 
unknown self-antigens in addition to the MBP-specificity, 
are crucial to prevent disease (35–37). Where and how TCR- 
PLP2 cells are primed at the onset of EAE in TCR-PLP2 Rag1–/– 
mice remain to be established. Yet, the spontaneous occur-
rence of disease in these animals illustrates that the presumed 
“invisibility” of PLP epitope #2 and the ensuing “ignorance” 
of specific CD4 T cells reflects a rather fragile tolerance state 
that may depend upon a delicate balance of active control 
mechanisms.
In contrast to the observations with epitope #2, immunization 
with epitopes #1 or #3 failed to promote a recall response and 
lacked encephalitogenic potential, and epitope #1 reactive TCR 
transgenic CD4 T cells were subject to central tolerance induc-
tion in the thymus. We consider it likely that central tolerance 
induction generally applies to epitope #1-specific CD4 T  cells 
exceeding a certain affinity threshold and by inference also to 
epitope #3 reactive T cells. To which extent this occurs through 
clonal deletion or clonal diversion into the Treg lineage for a given 
epitope remains to be established. In this regard, the precise 
mapping of I-Ab restricted epitopes paves the way for future 
investigations at the polyclonal repertoire level with MHCII-
tetramer reagents.
Our findings establish several molecular and cellular details 
of how PLP is expressed and presented for central tolerance. 
First, the conditional ablation of PLP in TECs unequivocally 
established that intrathymic expression by epithelial cells was 
essential, excluding a scenario whereby extrathymically derived 
PLP may reach the thymus as blood-borne antigen or through 
import by migratory DCs (38–40). Second, Aire was crucially 
required for central tolerance induction in TCR-PLP1 cells. This 
was somewhat unexpected, given that intrathymic PLP transcrip-
tion, in contrast to “canonical” promiscuous gene expression, is 
not confined to Aire+ MHCIIhi mTECs, but occurs at comparable 
levels also in their Aireneg/lo MHCIIlo immature precursors as 
well as in cTECs (8, 41). In Aire–/– mTECs, PLP transcripts are 
reduced by about fivefold (41), possibly falling below a critical 
threshold for central tolerance induction. However, tolerogenic 
functions of Aire beyond the promotion of promiscuous gene 
expression, for instance through regulation of chemokine 
expression, cellular differentiation, or antigen presentation may 
also contribute (42–46). These considerations notwithstanding, 
the “late” deletion of TCR-PLP1 cells at the CD4 SP stage is 
consistent with PLP expression in cTECs being irrelevant. Third, 
endogenously expressed PLP is directly presented by TECs, 
indicating that there is no requirement for “antigen handover” 
from expressing TECs to thymic DCs (24). The latter has not only 
been reported for certain “neo-antigens” expressed in mTECs 
(47) but was also suggested to occur for physiologically expressed 
self-antigens (48, 49). However, ablation of DCs did not inter-
fere with central tolerance induction in the TCR-PLP1 model, 
whereas conversely, reduced direct presentation by mTECs in 
the C2TAkd system had a significant effect. Of note, the direct 
presentation of TEC-derived PLP contrasts with what has been 
reported for an epitope of another Myelin autoantigen, MBP, 
whose tolerogenic display in the thymus required hematopoietic 
APC-mediated presentation of MBP of non-hematopoietic ori-
gin (50). Direct MHCII-restricted presentation of endogenous 
antigens by TECs can be facilitated through routing of intracel-
lular material into autophagosomes (25, 51, 52), but whether this 
pathway is involved in central tolerance to PLP remains to be 
addressed.
Bypassing or eliminating the thymic checkpoint through 
adoptive transfer of TCR-PLP1 cells or conditional deletion 
of PLP in TECs, respectively, revealed that PLP epitope #1 is 
constitutively “visible” to specific CD4 T cells in the periphery. 
Intriguingly, whereas DCs were dispensable for central toler-
ance, the presentation of PLP in the periphery critically involved 
DCs, as evident from the failure of adoptively transferred TCR-
PLP1 cells to proliferate in ΔDC recipients or MHCII–/– → PlpWT 
BM chimeras. The exact source of PLP that is presented by 
DCs in the periphery remains to be identified, but the lack 
of proliferation of adoptively transferred TCR-PLP1 cells in 
MHCII+/+ → PlpKO BM chimeras indicates a non-hematopoietic 
origin. Along these lines, it will be interesting to establish the 
anatomical location and exact identity of the DC subset(s) by 
which PLP is peripherally acquired and presented; these cells 
obviously lack the capacity to efficiently migrate to the thymus 
and induce central tolerance.
A general defect in intrathymic expression of tissue-restricted 
antigens, for instance in Aire- or Fezf2-deficient mice (53, 54), 
or the selective interference with intrathymic expression of 
individual genes, as is the case for the eye autoantigen IRBP 
(55), can precipitate spontaneous autoimmunity. By contrast, 
the deficiency in central tolerance to epitope #1 in PlpΔTEC mice 
neither resulted in spontaneous EAE nor increased the suscep-
tibility to “induced” EAE, irrespective of whether or not these 
mice were TCR transgenic. This suggests a substantial degree 
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of “functional” redundancy between mTEC-mediated central 
tolerance and DC-mediated peripheral tolerance to PLP. At the 
mechanistic level, however, our data point toward a differential 
contribution of central and peripheral tolerance induction to 
recessive versus dominant modes of tolerance, that is, clonal 
deletion and anergy versus Treg induction, respectively. On the 
one hand, there was a similar peripheral CD4 T cell reduction 
in TCR-PLP1 mice on both PlpWT as well as PlpΔTEC background, 
indicating that deletional tolerance mechanisms also operate in 
the periphery. Likewise, the anergic state of the Foxp3– subset 
of TCR-PLP1+ cells in the periphery was independent of thymic 
PLP expression. On the other hand, however, the “normal” for-
mation of a PLP-specific peripheral Treg compartment appeared 
to depend upon thymic Treg induction by mTECs. Consistent 
with impaired dominant tolerance to PLP in the absence of 
central tolerance induction, PlpΔTEC mice exhibited a more 
severe EAE course than PlpWT mice when receiving adoptively 
transferred naïve TCR-PLP1 at the time of “active EAE immu-
nization” with PLP9–20.
TCR-PLP1 ΔDC mice represent an informative model 
regard ing the question to which extent the PLP-specific CD4 
T  cell repertoire is shaped by thymic output as opposed to 
peripheral encounter of self-antigen: regardless of the absence 
of DCs, the peripheral CD4 T cell pool in these mice essentially 
phenocopied that of DC-sufficient mice, arguing for a prevail-
ing influence of intrathymic tolerance induction. However, the 
maintenance and/or induction of the anergic state of the Foxp3– 
subset of TCR-PLP1+ cells in the periphery required antigen 
(re-)encounter on peripheral DCs.
In sum, our work provides a comprehensive analysis of the 
cellular and molecular determinants that specify self-tolerance 
to PLP, the major myelin protein, in BL/6 mice. Our findings 
reveal distinct levels of redundancy or non-redundancy in 
terms of central versus peripheral tolerance induction and how 
these relate to EAE susceptibility. The definition of the I-Ab-
restricted CD4 T cell epitopes of PLP in conjunction with the 
comprehensive analysis of the tolerance modes that apply to 
these epitopes will lead the way to a deeper understanding of 
how repertoires directed against different epitopes of the very 
same CNS autoantigen may cooperate during disease induction 
and resolution.
MaTerials anD MeThODs
Mice
MHC class II–/– (H2-Ab1–/–) (56), C2TAkd (27), ΔDC (26), PlpKO 
(20), and Aire–/– (57) mice have been described previously. The 
gene encoding for PLP is located on the X chromosome. We did 
not observe any differences in the composition and phenotype 
of lymphoid compartments between TCR-PLP1 or TCR-PLP2 
transgenic PLP-sufficient females (Plp+/+) and males (Plp+/y) or 
between PLP-deficient females (Plp–/–) or males (Plp–/y). Therefore, 
female and male mice were included into the PLP-sufficient or 
-deficient groups and their genotype indicated as PlpWT or PlpKO. 
PlpΔTEC mice were obtained by crossing Foxn1-Cre (58) mice to 
mice carrying a conditional Plp allele in which exon 3 is flanked 
by loxP sites (Plpfl) (59). C57BL/6 mice were purchased from 
Charles River. Mice were maintained under specific pathogen-
free conditions in individually ventilated cages. All phenotypic 
analyses were performed in young adult mice at 4–5  weeks of 
age. Animal studies and procedures were approved by local 
authorities (Az 7-08 and 142-13).
To generate TCR transgenic mice, we used rearranged 
V(D)J regions of TCRs from PLP epitope #1 or #2-specific 
T  cell hybridomas (D9-119-2 or A43-11-5, respectively). 
Hybridoma D9-119-2 (TCR-PLP1) was obtained by 
immunizing PlpKO mice with peptide PLP1–25, repeated 
re-stimulation of draining LN cells with PLP9–20 and subse-
quent fusion with BW5147 cells. Its TCRα chain contains 
a rearrangement of Trav9d-3.201 (Vα3.2) and Traj34-201, 
the TCRβ chains harbors a Trbv19-201 (Vβ6), Trbd1, and 
Trbj1-1 rearrangement. Hybridoma A43-11-5 (TCR-PLP2) 
was obtained by immunizing PlpKO mice with peptide 
PLP160–184, repeated re-stimulation of draining LN cells 
with PLP172–183, and subsequent fusion with BW5147 cells. 
Its TCRα chain contains a Trav14-1-201 (Vα2) and Traj23-201 
rearrange ment, the TCRβ chain harbors a Trbv31-01 (Vβ14), 
Trbd1, and Trbj1-1 rearrangement. TCRα and TCRβ rearrange-
ments from the D9-119-2 and A43-11-5 hybridomas were PCR 
amplified and cloned into the cassette vectors pTαcass and 
pTβcass as described before (60). Transgenic mice were gener-
ated by injection of linearized DNA into pronuclei of C57BL/6 
zygotes.
antibodies and Flow cytometry
FITC-conjugated monoclonal antibodies (mAbs) to Vα3.2 
(RR3-16); PE-conjugated mAbs to Vβ6 (RR4-7), Vα2 (B20.1), 
and Vβ14 (14-2); CyChrome-conjugated mAbs to CD8 (53-6.7), 
PE-Cy7-conjugated streptavidin and mAbs to CD25 (PC61) 
and FR4 (12A5); APC-Cy7-conjugated mAbs to CD4 (GK1.5); 
biotin-conjugated mAbs to CD8 (53-6.7), CD4 (GK 1.5), B220 
(RA3-6B2) and Vα2 (B20.1); APC-conjugated mAbs to Foxp3 
(FJK-16s), CD45.2 (104); Pacific Blue-conjugated mAbs to 
CD45.1 (A20) were from BioLegend or eBiosciences, respec-
tively; flow cytometric analyses were performed on a FACSCanto 
II (BD) using FACSDiva (BD) and FlowJo (Tree Star) software.
Peptides and antigens
Purified human PLP (100% identical to mouse PLP) was pre-
pared as described (7). 25-mer peptides were synthesized in 
the central core facility of the DKFZ (8). 12-mer peptides were 
synthesized in the central core facility of the DKFZ or purchased 
from BioTrend.
epitope Prediction and In Silico analysis
The IEDB tool (http://www.iedb.org/) combines various machine 
learning algorithms for peptide epitope prediction in the context 
of a given MHC haplotype. The full-length PLP amino acid 
sequence was analyzed using the IEDB tool in the default “con-
sensus” setting for prediction methods (21, 22). A lower score 
indicates better binding to MHCII. The theoretical IC50 values 
were obtained with the SMM-align predictor (23).
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immunization and T cell Proliferation 
assays
Mice were immunized with 100 µg purified PLP or 50 µg pep-
tide emulsified in complete Freund’s adjuvant (volume/volume, 
1/1). After 9 days, popliteal and inguinal lymph node cells were 
harvested and cultured for 72 h in triplicate at a concentration 
of 4 × 105 cells/well in round-bottomed, 96-well plates in serum-
free medium (HL-1; BioWhittaker) in the presence or absence 
of titrated amounts of peptide or 5 µg/ml of the respective peptide 
for epitope mapping. Proliferation was measured by incorpora-
tion of 3H-thymidine, added for the last 24  h of culture at a 
concentration of 1 μCi/well. Only mice with comparable control 
responses to the complete Freund’s adjuvant component PPD 
were included in the analyses. Proliferation indices were calcu-
lated as 3H-Thymidin-incorporation in the presence of specific 
peptide divided by background proliferation w/o peptide. For 
direct ex vivo proliferation assays, 4 ×  105 T cells and 3 ×  104 
irradiated (3,000  rad) BM-derived DCs were cultured in the 
presence of increasing peptide concentrations.
BM chimeras
Bone marrow was depleted of B and T cells using biotinylated 
mAbs to B220, CD8, and CD4 and streptavidin MACS beads 
(Miltenyi Biotech). Female recipient mice were irradiated with 
2 × 550 rad and reconstituted with 5 × 106 BM cells.
adoptive T cell Transfer
TCR-PLP1 or TCR-PLP2 CD4+ T  cells were isolated from 
pooled lymph nodes and spleen by cell sorting or by depletion 
of CD25+ cells with biotin-conjugated anti-CD25 and anti-SAV 
MicroBeads followed by positive enrichment with anti-CD4 
microbeads (Miltenyi Biotech). T cells were labeled with CFSE 
(Life Technologies) and 5 × 106 T cells were injected i.v. into the 
lateral tail vein of congenic recipient mice. After 4 days, spleen 
or lymph node cells of recipient mice were analyzed by flow 
cytometry.
Th1 and Th17 Polarization
Naive CD4+ T cells were prepared from TCR-PLP1 PlpKO mice 
using the mouse CD4 T cell isolation kit (Miltenyi Biotech). For 
Th1 polarization, cells were incubated for 5  days in anti CD3 
(2C11) (5  µg/ml) coated 12-well plates (1 ×  106 cells/well) in 
the presence of recombinant IL-2 (5 ng/ml), recombinant IL-12 
(10  ng/ml), anti-CD28 mAb (37.51) (3  µg/ml), and anti-IL-4 
mAb (11B11) (10  µg/ml). For Th17 polarization, cells were 
stimulated in the presence of IL-6 (50 ng/ml), IL-1β (10 ng/ml), 
TGF-β1 (1 ng/ml), anti-CD28 (5 µg/ml), anti-IL-4 (10 µg/ml), 
anti-IFN-γ (XMG1.2) (10  µg/ml), and anti-IL-2 (JES6-1A2) 
(10  µg/ml). To verify successful polarization, cells were re-
stimulated on day 5 with PMA and ionomycin for 5  h and 
stained intracellularly for expression of lineage-specific effector 
cytokines (IFN-γ and IL-17).
In Vito suppression assay
TCR-PLP1+CD25+ cells were sorted from TCR-PLP1 PlpWT 
mice (CD45.2) and co-cultured at different ratios with 2 × 104 
CFSE-labeled TCR-PLP1+CD25– responder cells (CD45.1) from 
TCR-PLP1 PlpKO mice in the presence of 2 × 105 irradiated spleen 
APCs and 5 µg/ml peptide PLP9–20. After 4 days, CFSE dilution in 
gated CD45.1+ cells was analyzed by flow cytometry.
experimental autoimmune 
encephalomyelitis
For “active EAE” induction, mice were immunized subcutane-
ously at three sites on the flanks with 200  µg peptide PLP9–20, 
PLP172–183, or PLP238–249 in a total of 200  µl PBS/CFA emulsion 
(1:1). Pertussis toxin (400 ng) was given on days 0 and 2. In some 
experiments, mice received 5 ×  106 naïve TCR-PLP1 cells 6  h 
prior to the immunization. Signs of EAE were scored as follows: 
0, none; 0.5, partial loss of tail tonus; 1, limp tail; 1.5, wobbly gait 
and limb tail; 2.5, paralysis of one hind leg; 3, hind-limb paralysis 
on both sides; 3.5, hind-limb and partial front limbparalysis; 
4, complete hind-limb and forelimb paralysis; 5, moribund. 
Disease incidence and scores were measured daily. For “passive 
EAE” induction with Th1 or Th17 cells, Rag1–/– PlpWT recipients 
were injected i.v. with 5 × 106 in vitro polarized TCR-PLP1 cells. 
Scoring was carried out as described above.
Preparation of Thymic stromal cells  
and Quantitative Pcr
Thymic stromal cells were isolated as described (61). TEC 
sub types were classified according to the following surface phe-
notypes: cTECs, CD45−EpCAM+Ly51+CD80−; mTEChi, CD45− 
EpCAM+Ly51−CD80hiMHCIIhi; mTEClo, and CD45−EpCAM+ 
Ly51−CD80loMHCIIlo. RNA was isolated from sorted cells using 
the miRNAeasy kit including a DNase digest (Qiagen) and reverse 
transcribed using the iScript cDNA synthesis kit (Bio-Rad). PCR 
reactions were performed in duplicates on a CFX96 real-time 
thermal cycler (Bio-Rad) using the Ssofast EvaGreen Supermix 
(Bio-Rad). Fluorescence was recorded at the annealing step and 
relative expression levels were calculated with the comparative 
Ct method, using HPRT as housekeeping gene for normalization. 
Primers: Plp-forward, GGGCTTGTTAGAGTGTTGTGC; Plp-
reverse, GAAGAAGAAAGAGGCAGTTCCA; Hprt-forward, TG 
AAGAGCTACTGTAATGATCAGTCAAC; Hprt-reverse, AGCA 
AGCTTGCAACCTTACCA.
statistical analysis
Unless indicated otherwise, statistical significance was assessed 
using the two-tailed unpaired Student’s t-test with Welch’s cor-
rection for unequal variances.
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